跳至主要内容
临床试验/NCT01765764
NCT01765764已完成3 期

Bimatoprost for the Treatment of Eyebrow Hypotrichosis

Allergan0 个研究点目标入组 357 人开始时间: 2013年3月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Allergan
入组人数
357
主要终点
Percentage of Participants With at Least a 1-Grade Increase (Improvement) in the 4-Point Global Eyebrow Assessment (GEBA) Scale

研究概览

简要总结

This study will evaluate the safety and efficacy of bimatoprost solution compared with vehicle in the treatment of eyebrow hypotrichosis (inadequate eyebrows).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult participants with eyebrow hypotrichosis (inadequate eyebrow growth).

排除标准

  • Patients with disease, infection, or abnormality of the eyebrow area
  • Patients with permanent eyebrow loss due to over-grooming

研究组 & 干预措施

Bimatoprost Solution BID

Experimental

Bimatoprost solution twice a day (BID) in the morning and in the evening applied to each eyebrow for 7 months.

干预措施: bimatoprost solution (Drug)

Bimatoprost Solution QD

Experimental

Vehicle to bimatoprost solution in the morning and bimatoprost solution once a day (QD) in the evening applied to each eyebrow for 7 months.

干预措施: bimatoprost solution (Drug)

Bimatoprost Solution QD

Experimental

Vehicle to bimatoprost solution in the morning and bimatoprost solution once a day (QD) in the evening applied to each eyebrow for 7 months.

干预措施: Vehicle to bimatoprost solution (Drug)

Vehicle to Bimatoprost Solution BID

Placebo Comparator

Vehicle to bimatoprost twice a day (BID) in the morning and the evening applied to each eyebrow for 7 months.

干预措施: Vehicle to bimatoprost solution (Drug)

结局指标

主要结局

Percentage of Participants With at Least a 1-Grade Increase (Improvement) in the 4-Point Global Eyebrow Assessment (GEBA) Scale

时间窗: Baseline, Month 7

The physician evaluated eyebrow fullness using the 4-point GEBA Scale where: 1=very sparse, 2=sparse, 3=full and 4=very full. The percentage of participants with at least a 1-grade increase from Baseline is reported.

次要结局

  • Change From Baseline in Eyebrow Darkness as Measured Using DMSIA(Baseline, Month 7)
  • Change From Baseline in Eyebrow Fullness as Measured Using Digital Monitoring System Image Analysis (DMSIA)(Baseline, Month 7)
  • Percentage of Participants With 'Very Satisfied' or 'Mostly Satisfied' in Eyebrow Satisfaction Scale (ESS) Item #6(Month 7)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验

Bimatoprost for the Treatment of Eyebrow... | 临床试验